Search - tctmd.com

Displaying 101 - 120 of 268

Sort: Relevancy | Date

Presentation TVT 2021

Cerebral Embolic Protection: Updates From the Clinical Trials and Future Directions

Presenter: Samir Kapadia

July 21, 2021

Presentation TVT 2021

Does LAA Occlusion Make Sense in TAVR AF Patients: Updates From WATCH TAVR

Presenter: Amar Krishnaswamy

July 21, 2021

Presentation TCT 2020

Cerebral Embolic Protection and TAVR Outcomes: Results from the TVT Registry

Presenter: David Cohen

October 16, 2020

Presentation TCT 2020

A Randomized Evaluation oF the TriGUARD3™ Cerebral Embolic Protection Device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation The REFLECT II Trial

Presenter: Jeffrey W. Moses

October 15, 2020

Presentation TCT 2020

TCT 463: Computed Tomography Angiography-Fluoroscopy Fusion Imaging for the Guidance of Cerebral Embolic Protection Deployment During Transcatheter Aortic Valve Replacement

Presenter: Craig Basman

October 14, 2020

Presentation TCT 2020

TCT 484: Inclusion of Very Small Cerebral Lesions in Quantitative Embolic Protection Study Endpoints May Obscure Clinical Relevance

Presenter: Michael Dwyer

October 14, 2020

Presentation TCT 2020

TCT 471: A Novel Computed Tomographic Angiography Tortuosity Index to Predict Successful Sentinel Cerebral Embolic Protection Delivery for Transcatheter Aortic Valve Replacement

Presenter: Denny Wang

October 14, 2020

Presentation TCT 2020

TCT 366: Role of Embolic Protection Devices in Reducing Major Adverse Limb Events in Femoropopliteal Arterial Interventions in a Matched Cohort of Patients With Critical Limb Ischemia: Results From the XLPAD Registry.

Presenter: Qais Radaideh

October 14, 2020

Presentation Live Valves 2019

TAVI: Cerebral Protection for Everyone

Presenter: Susheel Kodali

December 10, 2019

Innovation Gone Wild - Next-Generation TRIGUARD Cerebral Embolic Protection During TAVR: Technology Review and Status of Ongoing Clinical Trials

Presentation TCT 2019

Next-Generation TRIGUARD Cerebral Embolic Protection During TAVR: Technology Review and Status of Ongoing Clinical Trials

Presenter: Tamim Nazif

September 27, 2019

Aortic Valve Intervention and Ancillary Solutions II - Total Embolic Protection: The Emboliner Embolic Protection Catheter, Early Clinical Results

Presentation TCT 2019

Total Embolic Protection: The Emboliner Embolic Protection Catheter, Early Clinical Results

Presenter: Scott Russell

September 25, 2019

Aortic Valve Intervention and Ancillary Solutions I: Featured Technological Trends - Full Arch Cerebral Embolic Protection of the Brain (Point-Guard™) During Cardiovascular Procedures

Presentation TCT 2019

Full Arch Cerebral Embolic Protection of the Brain (Point-Guard™) During Cardiovascular Procedures

Presenter: Axel Linke

September 25, 2019

Presentation TCT 2019

TCT 24: Clinical predictors for procedural stroke and implications for embolic protection device during TAVI: Results from the multicenter Transcatheter Aortic valve implantation in-hoSpital stroKe (TASK) study

Presenter: Amit Segev

September 25, 2019

Presentation TCT 2019

TCT 23: Heterogeneity of Debris Captured by Cerebral Embolic Protection Filters During Transcatheter Aortic Valve Replacement With Different Transcatheter Heart Valves

Presenter: Nicolas van Mieghem

September 25, 2019

Presentation TCT 2019

Distal Embolic Protections Are Expensive and Have Inherent Risks: When Are They Absolutely Necessary?

Presenter: Peter Schneider

September 25, 2019

Featured Technological Trends - A Novel Technique to Detect Spontaneously Ruptured Aortic Plaques as a Potential Cause of Embolic Strokes: An Innovative Application of Non-Obstructive Angioscopy(Nuvera)

Presentation TCT 2019

A Novel Technique to Detect Spontaneously Ruptured Aortic Plaques as a Potential Cause of Embolic Strokes: An Innovative Application of Non-Obstructive Angioscopy (Nuvera)

Presenter: Yoshiharu Higuchi

September 25, 2019

Presentation TVT 2019

Operator and Institutional Requirements for PFO Closure for Secondary Prevention of Paradoxical Embolic Stroke

Presenter: Zahid Amin

June 14, 2019

Presentation TVT 2019

PFO Closure for Secondary Prevention of Paradoxical Embolic Stroke: Randomized Trial Synthesis

Presenter: Fabian Nietlispach

June 14, 2019

Presentation TVT 2019

Cerebral Embolic Protection for TAVR With TriGuard 3: Updates From the REFLECT Clinical Trial

Presenter: Tamim Nazif

June 13, 2019

Presentation TVT 2019

Comprehensive Review of the Sentinel Cerebral Embolic Protection Program

Presenter: Julia Seeger

June 13, 2019

Advertisement

Cerebral Embolic Protection: Updates From the Clinical Trials and Future Directions

Does LAA Occlusion Make Sense in TAVR AF Patients: Updates From WATCH TAVR

Cerebral Embolic Protection and TAVR Outcomes: Results from the TVT Registry

A Randomized Evaluation oF the TriGUARD3™ Cerebral Embolic Protection Device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation The REFLECT II Trial

TCT 463: Computed Tomography Angiography-Fluoroscopy Fusion Imaging for the Guidance of Cerebral Embolic Protection Deployment During Transcatheter Aortic Valve Replacement

TCT 484: Inclusion of Very Small Cerebral Lesions in Quantitative Embolic Protection Study Endpoints May Obscure Clinical Relevance

TCT 471: A Novel Computed Tomographic Angiography Tortuosity Index to Predict Successful Sentinel Cerebral Embolic Protection Delivery for Transcatheter Aortic Valve Replacement

TCT 366: Role of Embolic Protection Devices in Reducing Major Adverse Limb Events in Femoropopliteal Arterial Interventions in a Matched Cohort of Patients With Critical Limb Ischemia: Results From the XLPAD Registry.

TAVI: Cerebral Protection for Everyone

Next-Generation TRIGUARD Cerebral Embolic Protection During TAVR: Technology Review and Status of Ongoing Clinical Trials

Total Embolic Protection: The Emboliner Embolic Protection Catheter, Early Clinical Results

Full Arch Cerebral Embolic Protection of the Brain (Point-Guard™) During Cardiovascular Procedures

TCT 24: Clinical predictors for procedural stroke and implications for embolic protection device during TAVI: Results from the multicenter Transcatheter Aortic valve implantation in-hoSpital stroKe (TASK) study

TCT 23: Heterogeneity of Debris Captured by Cerebral Embolic Protection Filters During Transcatheter Aortic Valve Replacement With Different Transcatheter Heart Valves

Distal Embolic Protections Are Expensive and Have Inherent Risks: When Are They Absolutely Necessary?

A Novel Technique to Detect Spontaneously Ruptured Aortic Plaques as a Potential Cause of Embolic Strokes: An Innovative Application of Non-Obstructive Angioscopy (Nuvera)

Operator and Institutional Requirements for PFO Closure for Secondary Prevention of Paradoxical Embolic Stroke

PFO Closure for Secondary Prevention of Paradoxical Embolic Stroke: Randomized Trial Synthesis

Cerebral Embolic Protection for TAVR With TriGuard 3: Updates From the REFLECT Clinical Trial

Comprehensive Review of the Sentinel Cerebral Embolic Protection Program

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content